Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Samsung and SK Hynix delay the adoption of hybrid bonding packaging technology as the industry's urgency has greatly diminished

Samsung and SK Hynix delay the adoption of hybrid bonding packaging technology as the industry's urgency has greatly diminished

格隆汇格隆汇2026/07/09 10:01
Show original
Glonhui July 9th|According to market sources, Samsung Electronics and SK Hynix originally planned to use hybrid bonding technology for HBM4, but are currently reconsidering. Hybrid bonding is an advanced semiconductor packaging technology, and the industry expects it to be first used for 16-layer HBM4E. The two companies have reportedly decided to continue using traditional thermocompression bonding technology due to the industry's relaxation of HBM thickness standards and delayed adjustments to customer high-stacking requirements.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11